Fatal disseminated varicella zoster infection following zoster vaccination in an immunocompromised patient

BMJ Case Reports

Volumn 2016, Issue , 2016, Pages

  Costa, E ^a   Buxton, J ^b   Brown, J ^c   Templeton, K E ^a   Breuer, J ^c   Johannessen, I ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b BORDERS GENERAL HOSPITAL   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYCLOPHOSPHAMIDE; FLUDARABINE; GANCICLOVIR; GENTAMICIN; IMMUNOGLOBULIN; PIPERACILLIN; RITUXIMAB; TAZOBACTAM; VARICELLA ZOSTER VACCINE;

AGED; ANTIMICROBIAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BODY FLUID; BODY TEMPERATURE; CANCER CHEMOTHERAPY; CASE REPORT; CAUSE OF DEATH; DETERIORATION; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; EXTUBATION; FEVER; FLU LIKE SYNDROME; HERPES ZOSTER; HUMAN; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; KIDNEY FAILURE; LETHARGY; LIVER FAILURE; LUNG LAVAGE; LYMPHATIC LEUKEMIA; MALAISE; MALE; MULTIPLE ORGAN FAILURE; PANCYTOPENIA; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RIGOR; THORAX RADIOGRAPHY; VACCINATION; VESICLE FLUID; VESICULAR RASH; VIRUS PNEUMONIA; VIRUS REACTIVATION; CHRONIC LYMPHATIC LEUKEMIA; COMPLICATION; FATALITY; RENAL INSUFFICIENCY; RESPIRATORY INSUFFICIENCY;

ACYCLOVIR; AGED; FATAL OUTCOME; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; RENAL INSUFFICIENCY; RESPIRATORY INSUFFICIENCY;

EID: 84969931166     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2015-212688     Document Type: Article

References (12)

1. Quinlivan M, Breuer J. Clinical and molecular aspects of the live attenuated Oka varicella vaccine. Rev Med Virol 2014;24:254-73.
2. Gomi Y, Sunamachi H, Mori Y, et al. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol 2002;76:11447-59.
3. World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec 2014;89:265-88.
4. Bhalla P, Forrest GN, Gershon M, et al. Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation. Clin Infect Dis 2015;60:1068-74.
5. Leung J, Siegel S, Jones JF, et al. Fatal varicella due to the vaccine-strain varicella-zoster virus. Hum Vaccine Immunother 2014;10:146-9.
6. Schrauder A, Henke-Gendo C, Seidemann K, et al. Varicella vaccination in a child with acute lymphoblastic leukaemia. Lancet 2007;369:1232.
7. Public Health England. Shingles (herpes zoster). The Green Book 2014; chapter 28a September 2014. URL: https://www.gov.uk/government/uploads/system/ uploads/attachment-data/file/357155/Green-Book-Chapter-28a-v0-5.pdf, 6th July 2015.
8. Health Protection Scotland. Administration of shingles (herpes zoster) vaccine (live) Zostavax® . Version 2.0 issued 06/10/14 following updates to shingles chapter of Green Book. URL: http://www.documents.hps.scot.nhs.uk/immunisation/shingles/ pgd-shingles-vaccine-2014-v2.0.pdf, 6th July 2015.
9. Herpes zoster (shingles) immunisation programme 2013/2014: Report for England. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/ 383018/ShinglesReport2014.pdf, 24th March 2016.
10. Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 2015;372:2087-96.
11. Stadtmauer EA, Sullivan KM, Marty FM, et al. A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood 2014;124:2921-9.
12. Cunningham AL. The herpes zoster subunit vaccine. Expert Opin Biol Ther 2016;16:265-71.